Growth hormone therapy and its relationship to insulin resistance, glucose intolerance and diabetes mellitus: a review of recent evidence (Q34595164)

3 August 2017

1 reference

title

Growth hormone therapy and its relationship to insulin resistance, glucose intolerance and diabetes mellitus: a review of recent evidence (English)

1 reference

3 August 2017

1 reference

1 reference

1 reference

William Jeffcoate

1

1 reference

3 August 2017

1 January 2002

1 reference

3 August 2017

1 reference

3 August 2017

25

1 reference

3 August 2017

3

1 reference

3 August 2017

199-212

1 reference

https://scigraph.springernature.com/pub.10.2165/00002018-200225030-00005

3 August 2017

0 references

cites work

The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults. KIMS Study Group and the KIMS International Board.

1 reference

12 December 2020

Insulin resistance and cardiovascular disease

1 reference

12 December 2020

Growth hormone (GH) replacement reduces total body fat and normalizes insulin sensitivity in GH-deficient adults: a report of one-year clinical experience

1 reference

12 December 2020

Growth hormone and metabolism

1 reference

12 December 2020

A therapeutic trial of growth hormone in hypopituitary adults and its influence upon continued prescription by general practitioners.

1 reference

12 December 2020

Growth hormone deficiency and cardiovascular risk

1 reference

12 December 2020

Safety of recombinant deoxyribonucleic acid-derived growth hormone: The National Cooperative Growth Study experience

1 reference

12 December 2020

Near normalization of adolescent height with growth hormone therapy in very short children without growth hormone deficiency

1 reference

12 December 2020

Effect of long-term growth hormone treatment on carbohydrate metabolism in children with growth hormone deficiency.

1 reference

12 December 2020

The genetic basis of type 2 diabetes mellitus: impaired insulin secretion versus impaired insulin sensitivity.

1 reference

12 December 2020

Insulin-like growth factor I and growth hormone (GH) treatment in GH-deficient humans: differential effects on protein, glucose, lipid, and calcium metabolism.

1 reference

12 December 2020

Discontinuation of growth hormone (GH) treatment: metabolic effects in GH-deficient and GH-sufficient adolescent patients compared with control subjects. Swedish Study Group for Growth Hormone Treatment in Children

1 reference

12 December 2020

Premature mortality due to cardiovascular disease in hypopituitarism

1 reference

12 December 2020

Cardiovascular disease and risk factors in adults with hypopituitarism

1 reference

12 December 2020

Long-term effects of growth hormone (GH) replacement in men with childhood-onset GH deficiency

1 reference

12 December 2020

Impaired glucose tolerance and dyslipidaemia as late effects after bone-marrow transplantation in childhood.

1 reference

12 December 2020

Effects of 7 years of growth hormone replacement therapy in hypopituitary adults.

1 reference

12 December 2020

Life expectancy following surgery for pituitary tumours

1 reference

12 December 2020

Dose titration and patient selection increases the efficacy of GH replacement in severely GH deficient adults

1 reference

12 December 2020

The effect of growth hormone replacement on cortisol metabolism and glucocorticoid sensitivity in hypopituitary adults.

1 reference

12 December 2020

Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus: problems and prospects.

1 reference

12 December 2020

Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee.

1 reference

12 December 2020

"Normal" blood glucose and coronary risk

1 reference

12 December 2020

Increased cerebrovascular mortality in patients with hypopituitarism

1 reference

12 December 2020

Incidence of diabetes mellitus and impaired glucose tolerance in children and adolescents receiving growth-hormone treatment.

1 reference

12 December 2020

The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity, and cardiovascular risk factors in hypopituitary adults.

1 reference

12 December 2020

Effects of four years' treatment with biosynthetic human growth hormone (GH) on glucose homeostasis, insulin secretion and lipid metabolism in GH-deficient adults.

1 reference

12 December 2020

Recombinant human insulin-like growth factor I has significant anabolic effects in adults with growth hormone receptor deficiency: studies on protein, glucose, and lipid metabolism

1 reference

12 December 2020

The safety profile of GH replacement therapy in adults.

1 reference

12 December 2020

Continuation of growth hormone (GH) therapy in GH-deficient patients during transition from childhood to adulthood: impact on insulin sensitivity and substrate metabolism.

1 reference

12 December 2020

Growth hormone (GH) replacement therapy reduces serum sialic acid concentrations in adults with GH-deficiency: a double-blind placebo-controlled study.

1 reference

12 December 2020

Eternal vigilance--mortality in children with growth hormone deficiency

1 reference

12 December 2020

Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease

1 reference

12 December 2020

Aortic distensibility in growth hormone deficient adults

1 reference

12 December 2020

Subclinical states of glucose intolerance and risk of death in the U.S.

1 reference

12 December 2020

Mortality, neoplasia, and Creutzfeldt-Jakob disease in patients treated with human pituitary growth hormone in the United Kingdom

1 reference

12 December 2020

Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of european prospective investigation of cancer and nutrition (EPIC-Norfolk)

1 reference

12 December 2020

Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two year study

1 reference

12 December 2020

Consequences of the new diagnostic criteria for diabetes in older men and women. DECODE Study (Diabetes Epidemiology: Collaborative Analysis of Diagnostic Criteria in Europe)

1 reference

12 December 2020

Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group

1 reference

12 December 2020

Can growth hormone therapy cause diabetes?

1 reference

12 December 2020

GH replacement in 1034 growth hormone deficient hypopituitary adults: demographic and clinical characteristics, dosing and safety

1 reference

12 December 2020

The effect of hypopituitarism on life expectancy

1 reference

12 December 2020

Treatment of a pituitary dwarf with human growth hormone

1 reference

12 December 2020

The effects of short and long-term growth hormone replacement therapy in hypopituitary adults on lipid metabolism and carbohydrate tolerance.

1 reference

12 December 2020

Blockade of the growth hormone (GH) receptor unmasks rapid GH-releasing peptide-6-mediated tissue-specific insulin resistance

1 reference

12 December 2020

Growth hormone therapy in adults and children

1 reference

12 December 2020

Effect of growth hormone on carbohydrate and lipid metabolism

1 reference

12 December 2020

Metabolic consequences of 5-year growth hormone (GH) therapy in children treated with GH for idiopathic short stature. Genentech Collaborative Study Group.

1 reference

12 December 2020

Continuation of growth hormone (GH) replacement in GH-deficient patients during transition from childhood to adulthood: a two-year placebo-controlled study.

1 reference

12 December 2020

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

12 December 2020

Circulating levels of incretin hormones and amylin in the fasting state and after oral glucose in GH-deficient patients before and after GH replacement: a placebo-controlled study.

1 reference

12 December 2020

The Australian Multicenter Trial of Growth Hormone (GH) Treatment in GH-Deficient Adults.

1 reference

12 December 2020

Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults.

1 reference

12 December 2020

Growth hormone deficiency and replacement in elderly hypopituitary adults. KIMS Study Group and the KIMS International Board. Pharmacia and Upjohn International Metabolic Database

1 reference

12 December 2020

The effect of 30 months of low-dose replacement therapy with recombinant human growth hormone (rhGH) on insulin and C-peptide kinetics, insulin secretion, insulin sensitivity, glucose effectiveness, and body composition in GH-deficient adults.

1 reference

12 December 2020

Defects of insulin action and skeletal muscle glucose metabolism in growth hormone-deficient adults persist after 24 months of recombinant human growth hormone therapy.

1 reference

12 December 2020

Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment. Adult Growth Hormone Deficiency Study Group.

1 reference

12 December 2020

Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe

1 reference

12 December 2020

10.2165/00002018-200225030-00005

Identifiers

DOI

1 reference

PubMed ID

11945115

Dimensions Publication ID

3 August 2017

0 references

1 reference

PubMed ID

11945115